This opening article in our miniseries examines the importance of the gut microbiome and its role in influencing cancer risk.

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...

IMUNON’s Phase 2 OVATION 2 trial of IMNN-001 in advanced ovarian cancer showed a 13-month OS increase (46 vs. 33 months) and ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature ...

To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

The field of tumor immunology has highlighted the adeptness of tumor cells in evading the host's immune system. This insight has fueled interest in ...

The existence of specialised structures that allow a continuous exchange of CSF between different anatomical compartments at ...